First complete description of the aspirin idiosyncrasy-asthma-nasal polyposis syndrome (plus urticaria)--1922 (with a note on aspirin desensitization). By F. Widal, P. Abrami, J. Lermoyez.

Display options

Format

Share it on

J Asthma. 1987;24(5):297-300.

First complete description of the aspirin idiosyncrasy-asthma-nasal polyposis syndrome (plus urticaria)--1922 (with a note on aspirin desensitization). By F. Widal, P. Abrami, J. Lermoyez.

The Journal of asthma : official journal of the Association for the Care of Asthma

F Widal, P Abrami, J Lermoyez

PMID: 3327855

[No abstract available.]

Cited by

Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis.

Spielman DB, Overdevest J, Gudis DA.
World J Otorhinolaryngol Head Neck Surg. 2020 Aug 26;6(4):207-213. doi: 10.1016/j.wjorl.2020.07.001. eCollection 2020 Dec.
PMID: 33336175

Samter's Triad: State of the Art.

Kim SD, Cho KS.
Clin Exp Otorhinolaryngol. 2018 Jun;11(2):71-80. doi: 10.21053/ceo.2017.01606. Epub 2018 Apr 13.
PMID: 29642688

Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management.

Li KL, Lee AY, Abuzeid WM.
Med Sci (Basel). 2019 Mar 17;7(3). doi: 10.3390/medsci7030045.
PMID: 30884882

Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease.

Sehanobish E, Asad M, Barbi M, Porcelli SA, Jerschow E.
Front Immunol. 2021 Jun 25;12:695815. doi: 10.3389/fimmu.2021.695815. eCollection 2021.
PMID: 34305932

Lung function and side effects of Aspirin desensitization: a real world study.

Heikki T, Anu LH, Annina L, Jura N, Elina P, Sahlman J, Sanna TS, Paula K.
Eur Clin Respir J. 2021 Jan 11;8(1):1869408. doi: 10.1080/20018525.2020.1869408.
PMID: 33520120

First complete description of the aspirin idiosyncrasy-asthma-nasal polyposis syndrome (plus urticaria)--1922 (with a note on aspirin desensitization). By F. Widal, P. Abrami, J. Lermoyez.

Cited by

Substances

MeSH terms

Publication Types

LinkOut - more resources